Research report
A research report is the sourced material a domain
dossier is synthesized from — generated on a plan and a cadence, one topic per file.
A report carries no confidence tags. Its bracketed markers say who might have
an incentive to shade a line; none of them says anyone checked it. To reach a score, a line has
to be drafted onto a candidate as unverified and pass the Verifier or the
Corroborator, like everything else.
Section care-pathway · Version 2026-09-01 · Cadence annual · Evidence class 2 published · Sources 10 · Supersedes none
Domain: veterinary-diabetes-glucose-monitoring · Scope: public primary sources reachable by this repo's connectors, WebSearch and WebFetch. No US federal dataset covers veterinary procedure volume, staffing, or site-of-service mix, so findings here are limited to what veterinary peer-reviewed literature and the practice-guideline record actually report. Excludes AAHA's own guideline web page (fda.gov-style bot mitigation, per the domain dossier), MAUDE narratives (no connector), and any veterinary-technician-specific time-and-motion study, none of which surfaced in this pass.
Sourcing: nine peer-reviewed veterinary studies (mostly single-institution surveys and cohorts) plus one peer-reviewed practice guideline read at abstract depth; two independent studies agree that off-label sensors are applied to the thoracic wall, and everything else — the owner-education gap at diagnosis, home-monitoring uptake rates, and species differences in tolerance — rests on one study apiece.
The domain dossier's care-pathway section was built from a single finding (in-hospital stress hyperglycemia in cats); this report adds the surrounding pathway detail that finding sits inside. Two independent, differently-designed studies agree that the off-label sensor (FreeStyle Libre) is applied to the thoracic wall rather than any other body site, which is plainly stated below [3][4]. Everything else here is single-study: the practice guideline frames owner home monitoring as encouraged but not mandatory [1]; a UK owner survey found the majority of veterinarians did not discuss home monitoring at diagnosis even though most owners ended up doing it anyway [5]; and one small cat-only-practice cohort describes an alternative pathway that substitutes home spot-checks for in-clinic serial curves entirely [7]. None of this settles how the pathway is distributed across the US veterinary population — that remains the same gap the dossier already names.
_Baseline (v1). No prior version; this establishes the starting point for future diffs._
The only practice-guideline document located for this pathway is the American Animal Hospital Association's 2018 diabetes management guideline, published as a peer-reviewed article rather than only a web page. Read at abstract depth (the full guideline text sits behind AAHA's own site, which the domain dossier already records as unretrieved), its own summary states the guideline's position on where monitoring happens:
"An essential aspect of successful DM management is to ensure that the owner of a diabetic dog or cat is capable of administering insulin, recognizing the clinical signs of inadequately managed DM, and monitoring blood glucose levels at home, although this is ideal but not mandatory." — PMID 29314873 [single-source · paywalled]
That single sentence is the only guideline-level statement this pass could retrieve on site-of-service: home monitoring is framed as desirable, not required, which leaves the actual split between in-clinic and home monitoring to be settled by practice, not guideline mandate — exactly what the rest of this section describes.
The domain dossier's care-pathway section already carries one finding on this point in full; it is repeated here only long enough to connect it to site-of-service choice, since it is the one documented, measured reason a clinic visit is not a neutral place to construct a glucose curve. A study of 10 healthy cats measured hourly at home and during hospitalisation found:
"Stress-induced hyperglycaemia was observed in the hospital. The acclimatisation cut-off time for the cats' return to euglycaemia was 6 h... Elevated HR, RR, CSS, glucose and cortisol concentrations were observed in cats at the hospital compared with those at home (P <0.001)." — PMID 40230085 [2] [single-source]
The study measured healthy cats, not diabetic ones, and its own authors note that "similar studies in sick cats should be conducted" — so it establishes that hospitalisation itself measurably elevates glucose in cats generally, not that every in-clinic diabetic glucose curve in the literature was confounded by it [single-source].
Two independent, unaffiliated prospective/retrospective studies of the off-label flash glucose monitor in diabetic cats agree that the sensor is applied to the thoracic wall rather than any other site on the animal, which is stated plainly for that reason. A retrospective review of 33 sensor placements in 20 diabetic cats at one institution found:
"The majority (30/33 [91%]) of sensors were placed over the dorsolateral aspect of the thorax just caudal to the scapula." — PMID 33078691 [single-source]
A separate prospective study of 41 client-owned diabetic cats, evaluating the same device class, reports placement at the same general site without the same precision:
"Most sensors were placed on the thoracic wall... Placing the device was easy, with 70% of cats showing no reaction." — PMID 35762266 [single-source]
The specific 91% figure and the 70%-no-reaction figure are each single-study findings; only the underlying site (thoracic wall) is corroborated across the two. Sensor functional life in the same two studies is reported as a median of 10 days (range 1–14) in the 41-cat study and elsewhere in this domain's dossier as a median of 8.3 days (range 1.6–14) in a 34-cat/66-sensor study — different cohorts, not the same number, and each remains attached to its own source [3][4].
A 748-owner survey of feline diabetes management on a veterinary-professional-run client platform found a gap between what gets discussed at diagnosis and what owners subsequently do:
"At diagnosis, fewer than half of veterinarians discussed how to recognise unstable diabetes (46%) or home blood glucose monitoring (HBGM) (40%)... Only 49% of respondents were supervised by a veterinarian/veterinary nurse while first drawing up insulin and injecting their cat... impressively, 71% of owners used HBGM." — PMID 31241424 [single-source]
A separate, smaller prospective study offering a standardized instruction session to owners of 38 recently diagnosed diabetic cats found a comparable adoption rate reached through a different mechanism — structured onboarding rather than owner-initiated uptake:
"Thirty-eight cats were enrolled; 28 (74%) entered the HBGM group [after a standardised instruction session]." — PMID 28911254 [single-source]
The same study found no significant difference in overall quality-of-life score or most glycemic-control parameters between the home-monitoring and non-home-monitoring groups at 6 months, but did find remission in 9/28 (32%) of the home-monitoring group versus 1/10 (10%) of the non-home-monitoring group (reported as not statistically significant, P=0.236) [single-source]. A retrospective cohort at a single cat-only practice describes a pathway that removes the in-clinic serial curve from the loop entirely, substituting only pre-insulin home glucose spot checks for dose adjustment in 174 newly diagnosed cats:
"Nearly 50% of cats with newly diagnosed diabetes achieved remission with this low-cost, moderate-intensity, insulin dosing protocol... A minority (16%) of cats were hospitalised for hypoglycaemia." — PMID 38661475 [single-source]
Two separate owner surveys, each single-source for its own figures, describe dogs and cats differently along different axes of the same pathway. A 50-owner survey of flash-glucose-monitor use found dogs' owners rated the device more favorably on tolerability and invasiveness than cats' owners did:
"A significantly higher number of dogs' owners found the FGMS to be well-tolerated (79% vs. 40%), less invasive than BGCs (79% vs. 43%), and easier to maintain in situ (76% vs. 43%) [compared with cats' owners]." — PMID 36977242 [single-source]
An 834-owner US survey of general diabetes-treatment experience (not sensor-specific) found the opposite framing on satisfaction and monitoring uptake — cat owners more satisfied with control and more likely to monitor at home than dog owners:
"More cat (66%) than dog (50%) owners were satisfied with the diabetic control achieved... Cat owners were more likely to use home blood glucose monitoring." — PMID 24855090 [single-source]
These are not the same claim measured twice — one is about tolerating an interstitial sensor, the other about satisfaction with insulin-injection-based management generally — so neither corroborates nor contradicts the other; both are carried here as separate, single-source species comparisons. A third, most recent owner survey (35 owners, 2026) of continuous glucose monitor use across both species found high overall satisfaction without breaking results out by species:
"Ninety-one percent would use the sensor again, and 94% would recommend it to other owners... Owners reported a moderate stress level for themselves (mean 4.57 ± 3.58, 0 to 10 scale)." — PMID 42478480 [single-source]
[1] 2018 AAHA Diabetes Management Guidelines for Dogs and Cats — Journal of the American Animal Hospital Association (published 2018, month given as Jan/Feb in the PubMed record; accessed 2026-09-01). PMID 29314873 — https://pubmed.ncbi.nlm.nih.gov/29314873/ [guideline] [2] Influence of hospital-induced stress on blood glucose concentrations, serum concentrations of cortisol, thyroxine and bile acids, and behaviour in cats — Journal of Feline Medicine and Surgery (published 2025, month not given in the PubMed record; accessed 2026-09-01). PMID 40230085 — https://pubmed.ncbi.nlm.nih.gov/40230085/ [peer-reviewed] [3] Complications associated with a flash glucose monitoring system in diabetic cats — Journal of Feline Medicine and Surgery (published 2021-06; accessed 2026-09-01). PMID 33078691 — https://pubmed.ncbi.nlm.nih.gov/33078691/ [peer-reviewed] [4] Evaluation of the FreeStyle Libre, a flash glucose monitoring system, in client-owned cats with diabetes mellitus — Journal of Feline Medicine and Surgery (published 2022-08; accessed 2026-09-01). PMID 35762266 — https://pubmed.ncbi.nlm.nih.gov/35762266/ [peer-reviewed] [5] Priorities on treatment and monitoring of diabetic cats from the owners' points of view — Journal of Feline Medicine and Surgery (published 2020-06; accessed 2026-09-01). PMID 31241424 — https://pubmed.ncbi.nlm.nih.gov/31241424/ [peer-reviewed] [6] Acceptance of home blood glucose monitoring by owners of recently diagnosed diabetic cats and impact on quality of life changes in cat and owner — Journal of Feline Medicine and Surgery (published 2018-08; accessed 2026-09-01). PMID 28911254 — https://pubmed.ncbi.nlm.nih.gov/28911254/ [peer-reviewed] [7] Frequency of diabetic remission, predictors of remission and survival in cats using a low-cost, moderate-intensity, home-monitoring protocol and twice-daily glargine — Journal of Feline Medicine and Surgery (published 2024-04; accessed 2026-09-01). PMID 38661475 — https://pubmed.ncbi.nlm.nih.gov/38661475/ [peer-reviewed] [8] Monitoring of Diabetes Mellitus Using the Flash Glucose Monitoring System: The Owners' Point of View — Veterinary Sciences (published 2023-03-07; accessed 2026-09-01). PMID 36977242 — https://pubmed.ncbi.nlm.nih.gov/36977242/ [peer-reviewed] [9] Owner experiences in treating dogs and cats diagnosed with diabetes mellitus in the United States — Journal of the American Animal Hospital Association (published 2014, month given as Jul-Aug in the PubMed record; accessed 2026-09-01). PMID 24855090 — https://pubmed.ncbi.nlm.nih.gov/24855090/ [peer-reviewed] [10] Owners' perspective on using a continuous glucose monitoring system with their diabetic pet — Journal of Small Animal Practice (published 2026-07-21; accessed 2026-09-01). PMID 42478480 — https://pubmed.ncbi.nlm.nih.gov/42478480/ [peer-reviewed]
Well established: that the off-label flash glucose monitor is applied to the thoracic wall in diabetic cats rests on two independent, unaffiliated studies (a single-institution retrospective review and a separate prospective client-owned-cat study) and is stated plainly for that reason [3][4].
Thin: every other line in this report — the guideline's "ideal but not mandatory" framing [1], the owner-education gap at diagnosis and the 71% eventual HBGM uptake [5], the 74% acceptance rate after structured instruction and its remission comparison [6], the low-cost home-only titration protocol's 47% remission rate [7], both species-comparison surveys [8][9], and the 2026 owner-satisfaction survey [10] — rests on a single study apiece and is marked [single-source]. The guideline citation [1] is additionally marked [paywalled]: only its PubMed abstract was read; the full guideline document, including any specific recommended monitoring interval or frequency, remains behind AAHA's own site, which the domain dossier already records as unretrieved on two separate fetch attempts.
Rescoped from class 3: none in this report. Every question addressed here — where a sensor is placed, what a guideline states, what owners were told and what they did anyway — is a registry-or-published-finding question in shape, not a question about what a person would do, so none required rescoping.
Out of scope: CPT descriptors and any HCPCS/CMS material (human-payer constructs with no veterinary counterpart, per the domain dossier's reimbursement section); MAUDE narratives (no connector in this repo); AAHA's own guideline web page (bot-mitigated, per the dossier).
Not searched vs. not found:
connectors trials, condition
terms "diabetic dog cat" and "diabetes mellitus canine feline") and returned zero records,
consistent with the domain dossier's point that no federal US trial registry reaches
veterinary studies structurally, not because this pathway went unsearched there.
[inference] None in this report's Details section. The observation that the guideline's "ideal but not mandatory" framing, the owner-education gap, and the eventual high home-monitoring uptake together describe a pathway driven more by owner initiative than by a structured clinic-side protocol is this writer's synthesis of [1], [5] and [6] taken together; no single source states that framing directly.
| Proposition | Evidence class | Resolvable identifier | Dossier section |
|---|---|---|---|
| In a retrospective review of 33 flash glucose monitoring system placements in 20 diabetic cats, 91% (30/33) were placed over the dorsolateral thorax just caudal to the scapula | 2 published | PMID 33078691 | care-pathway |
| The 2018 AAHA Diabetes Management Guidelines for Dogs and Cats describe owner home blood glucose monitoring as ideal but not mandatory | 2 published | PMID 29314873 | care-pathway |
| In a survey of 748 owners of diabetic cats, only 40% reported their veterinarian discussed home blood glucose monitoring at diagnosis, while 71% of owners used it regardless | 2 published | PMID 31241424 | care-pathway |
| In a prospective study of 38 recently diagnosed diabetic cats offered a standardized instruction session, 74% (28/38) adopted home blood glucose monitoring | 2 published | PMID 28911254 | care-pathway |
| In a retrospective cohort of 174 newly diagnosed diabetic cats managed with a low-cost, home-blood-glucose-only insulin titration protocol at a single cat-only practice, 47% achieved diabetic remission | 2 published | PMID 38661475 | care-pathway |
| In a 50-owner survey, dogs' owners rated a flash glucose monitoring system as better tolerated than cats' owners did (79% vs. 40%) | 2 published | PMID 36977242 | user-groups |